Balaxi Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended March 31, 2026. The company has received this confirmation from its Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited. The Registrar confirmed that for the period from January 1, 2026, to March 31, 2026, all actions related to the dematerialization of securities were completed within 15 days of receiving the certificates from depository participants. These actions include the mutilation and cancellation of original certificates, and updating the depository as the registered owner for securities that have been dematerialized and are listed on stock exchanges. The certificate will also be made available on the company's official website, www.balaxipharma.in, for public access. The announcement was made by Aman Purohit, Company Secretary & Compliance Officer of Balaxi Pharmaceuticals Limited.
